12/4
04:39 pm
mdt
Medtronic plc declares $0.71 dividend [Seeking Alpha]
Low
Report
Medtronic plc declares $0.71 dividend [Seeking Alpha]
12/4
04:32 pm
mdt
Medtronic announces cash dividend for third quarter of fiscal year 2026
Low
Report
Medtronic announces cash dividend for third quarter of fiscal year 2026
12/3
04:46 pm
mdt
Medtronic gets FDA clearance of Hugo robotic-assisted surgery system [Seeking Alpha]
Low
Report
Medtronic gets FDA clearance of Hugo robotic-assisted surgery system [Seeking Alpha]
12/3
04:32 pm
mdt
Medtronic (NYSE:MDT) had its "buy (b)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Medtronic (NYSE:MDT) had its "buy (b)" rating reaffirmed by analysts at
Weiss Ratings.
12/3
04:30 pm
mdt
Medtronic announces FDA clearance of Hugo™ robotic-assisted surgery system for urologic surgical procedures
Low
Report
Medtronic announces FDA clearance of Hugo™ robotic-assisted surgery system for urologic surgical procedures
12/2
09:00 am
mdt
Medtronic begins U.S. commercial launch of the MiniMed™ 780G system with the Instinct sensor, made by Abbott
Low
Report
Medtronic begins U.S. commercial launch of the MiniMed™ 780G system with the Instinct sensor, made by Abbott
11/29
01:23 pm
mdt
Medtronic (MDT) Price Target Raised as PFA Technology Drives Q2 Revenue Gains [Yahoo! Finance]
Low
Report
Medtronic (MDT) Price Target Raised as PFA Technology Drives Q2 Revenue Gains [Yahoo! Finance]
11/29
09:39 am
mdt
Medtronic (NYSE:MDT) had its price target raised by analysts at Daiwa Capital Markets from $104.00 to $117.00. They now have a "buy" rating on the stock.
Low
Report
Medtronic (NYSE:MDT) had its price target raised by analysts at Daiwa Capital Markets from $104.00 to $117.00. They now have a "buy" rating on the stock.
11/20
12:15 pm
mdt
Medtronic (NYSE:MDT) had its price target raised by analysts at Truist Financial Corporation from $103.00 to $110.00. They now have a "hold" rating on the stock.
Low
Report
Medtronic (NYSE:MDT) had its price target raised by analysts at Truist Financial Corporation from $103.00 to $110.00. They now have a "hold" rating on the stock.
11/20
10:05 am
mdt
Medtronic (NYSE:MDT) was given a new $111.00 price target on by analysts at Sanford C. Bernstein.
Low
Report
Medtronic (NYSE:MDT) was given a new $111.00 price target on by analysts at Sanford C. Bernstein.
11/20
09:05 am
mdt
Medtronic (NYSE:MDT) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
Medtronic (NYSE:MDT) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
11/20
06:02 am
mdt
Medtronic (NYSE:MDT) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "strong sell" rating to a "hold" rating.
Low
Report
Medtronic (NYSE:MDT) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "strong sell" rating to a "hold" rating.
11/19
12:38 pm
mdt
Medtronic (NYSE:MDT) had its price target raised by analysts at Morgan Stanley from $107.00 to $117.00. They now have an "overweight" rating on the stock.
Low
Report
Medtronic (NYSE:MDT) had its price target raised by analysts at Morgan Stanley from $107.00 to $117.00. They now have an "overweight" rating on the stock.
11/19
11:10 am
mdt
Medtronic (NYSE:MDT) had its price target raised by analysts at Royal Bank Of Canada from $111.00 to $118.00. They now have an "outperform" rating on the stock.
Low
Report
Medtronic (NYSE:MDT) had its price target raised by analysts at Royal Bank Of Canada from $111.00 to $118.00. They now have an "outperform" rating on the stock.
11/19
10:19 am
mdt
Medtronic (NYSE:MDT) had its price target raised by analysts at UBS Group AG from $95.00 to $102.00. They now have a "neutral" rating on the stock.
Low
Report
Medtronic (NYSE:MDT) had its price target raised by analysts at UBS Group AG from $95.00 to $102.00. They now have a "neutral" rating on the stock.
11/19
09:07 am
mdt
Medtronic (NYSE:MDT) had its price target raised by analysts at Wells Fargo & Company from $100.00 to $114.00. They now have an "overweight" rating on the stock.
Low
Report
Medtronic (NYSE:MDT) had its price target raised by analysts at Wells Fargo & Company from $100.00 to $114.00. They now have an "overweight" rating on the stock.
11/19
08:07 am
mdt
Medtronic (NYSE:MDT) had its price target raised by analysts at Robert W. Baird from $103.00 to $109.00. They now have a "neutral" rating on the stock.
Low
Report
Medtronic (NYSE:MDT) had its price target raised by analysts at Robert W. Baird from $103.00 to $109.00. They now have a "neutral" rating on the stock.
11/19
07:00 am
mdt
Medtronic (NYSE:MDT) was given a new $111.00 price target on by analysts at The Goldman Sachs Group, Inc..
Low
Report
Medtronic (NYSE:MDT) was given a new $111.00 price target on by analysts at The Goldman Sachs Group, Inc..
11/19
07:00 am
mdt
Medtronic (NYSE:MDT) was given a new $120.00 price target on by analysts at Leerink Partners.
Low
Report
Medtronic (NYSE:MDT) was given a new $120.00 price target on by analysts at Leerink Partners.
11/19
06:02 am
mdt
Medtronic (NYSE:MDT) had its "hold" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Low
Report
Medtronic (NYSE:MDT) had its "hold" rating reaffirmed by analysts at Jefferies Financial Group Inc..
11/18
02:11 pm
mdt
Medtronic PLC (MDT) Q2 2026 Earnings Call Highlights: Strong Revenue and EPS Growth Propel ... [Yahoo! Finance]
Low
Report
Medtronic PLC (MDT) Q2 2026 Earnings Call Highlights: Strong Revenue and EPS Growth Propel ... [Yahoo! Finance]
11/18
10:28 am
mdt
Hepatorenal Syndrome Analysis and Forecast Report 2025-2035: Market Led by Mallinckrodt, Noorik, BioVie, and Ferring as Innovation, Partnerships, and Market Expansion Drive Competitive Growth [Yahoo! Finance]
Low
Report
Hepatorenal Syndrome Analysis and Forecast Report 2025-2035: Market Led by Mallinckrodt, Noorik, BioVie, and Ferring as Innovation, Partnerships, and Market Expansion Drive Competitive Growth [Yahoo! Finance]
11/18
07:32 am
mdt
Earnings Snapshot: Medtronic tops FQ2 estimates; raises FY26 outlook above forecast [Seeking Alpha]
Low
Report
Earnings Snapshot: Medtronic tops FQ2 estimates; raises FY26 outlook above forecast [Seeking Alpha]
11/18
06:59 am
mdt
Medtronic in charts: FQ2 revenue from medical surgical portfolio +2%, cardiovascular +10.8% Y/Y [Seeking Alpha]
Low
Report
Medtronic in charts: FQ2 revenue from medical surgical portfolio +2%, cardiovascular +10.8% Y/Y [Seeking Alpha]
11/18
06:53 am
mdt
Medtronic reports strong second quarter fiscal 2026 financial results, enterprise growth drivers accelerate momentum [Yahoo! Finance]
Low
Report
Medtronic reports strong second quarter fiscal 2026 financial results, enterprise growth drivers accelerate momentum [Yahoo! Finance]